Weekly intermittent 2-CdA is less toxic and equally efficacious when compared to continuous infusion in hairy cell leukaemia [1]

British Journal of Haematology

Volumn 105, Issue 4, 1999, Pages 1145-1146

  Chacko, J ^a   Murphy, C ^a   Duggan, C ^a   O'Briain, D S ^a   Browne, P V ^a   McCann, S R ^a  

^a ST JAMES S HOSPITAL   (Ireland)

Author keywords

2 CdA therapy; Hairy cell leukaemia

Indexed keywords

CLADRIBINE; PENTOSTATIN;

ADULT; BONE MARROW TOXICITY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HAIRY CELL LEUKEMIA; HUMAN; HUMAN CELL; HUMAN TISSUE; LETTER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RASH; REMISSION;

ADULT; ANTIBIOTICS, ANTINEOPLASTIC; ANTINEOPLASTIC AGENTS; CLADRIBINE; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; LEUKEMIA, HAIRY CELL; MALE; MIDDLE AGED; PENTOSTATIN;

EID: 0032989147     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2141.1999.01523.x     Document Type: Letter

References (5)